PERSEUS SOROS BIOPHARMACEUTICAL FUND LP's Net Worth
$136 Million
Who is PERSEUS SOROS BIOPHARMACEUTICAL FUND LP?
PERSEUS SOROS BIOPHARMACEUTICAL FUND LP has an estimated net worth of $136 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., VALENTIS INC, AUXILIUM PHARMACEUTICALS INC, BARRIER THERAPEUTICS INC, Adams Respiratory Therapeutics, Inc., and BIOENVISION INC.
SEC CIK
PERSEUS SOROS BIOPHARMACEUTICAL FUND LP's CIK is 0001111408
Past Insider Trading and Trends
2004 was PERSEUS SOROS BIOPHARMACEUTICAL FUND LP's most active year for acquiring shares with 10 total transactions. PERSEUS SOROS BIOPHARMACEUTICAL FUND LP's most active month to acquire stocks was the month of June. 2004 was PERSEUS SOROS BIOPHARMACEUTICAL FUND LP's most active year for disposing of shares, totalling 7 transactions. PERSEUS SOROS BIOPHARMACEUTICAL FUND LP's most active month to dispose stocks was the month of June. 2007 saw PERSEUS SOROS BIOPHARMACEUTICAL FUND LP paying a total of $8,100,000.00 for 6,801,764 shares, this is the most they've acquired in one year. In 2005 PERSEUS SOROS BIOPHARMACEUTICAL FUND LP cashed out on 8,893,924 shares for a total of $108,874,655.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MAP Pharmaceuticals, Inc. No price found
InvestorPERSEUS SOROS BIOPHARMACEUTICAL FUND LP owns 1,826,169 units of Common Stock. In the year 2007 PERSEUS SOROS BIOPHARMACEUTICAL FUND LP filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.38% | -1.00M |
—
|
—
| 1.83M |
May 11
| |||
Form 4
| -30.67% | -1.25M |
—
|
—
| 2.83M |
Feb 11
| |||
Form 4
| +1,385.45% | 3.8M |
$12.00 |
—
| 4.08M |
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VALENTIS INC No price found
InvestorPERSEUS SOROS BIOPHARMACEUTICAL FUND LP owns 2,167,744 units of Common Stock, $.001 par value. In the year 2004 PERSEUS SOROS BIOPHARMACEUTICAL FUND LP filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +14.05% | 266.97K |
$2.05 | $547,292.60 | 2.17M |
Jan 29
| |||
Form 4
| +34.73% | 487.81K |
$2.05 | $1,000,000.25 | 1.89M |
Dec 31
| |||
| No matching records found | |||||||||
AUXILIUM PHARMACEUTICALS INC No price found
InvestorPERSEUS SOROS BIOPHARMACEUTICAL FUND LP owns 2,377,403 units of Common Stock. From 2004 to 2006 PERSEUS SOROS BIOPHARMACEUTICAL FUND LP acquired a total of 3,794,610 shares in AUXILIUM PHARMACEUTICALS INC at a cost of $3,374,236.10, PERSEUS also disposed a total of 1,500,000 shares of AUXILIUM PHARMACEUTICALS INC equalling to $24,000,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -38.69% | -1.50M |
$16.00 | -$24,000,000.00 | 2.38M |
Dec 5
| |||
Form 4
| +18.75% | 612.09K |
$4.90 | $2,999,236.10 | 3.88M |
Jun 30
| |||
Form 4
| +3,843.95% | 3.18M |
$7.50 |
—
| 3.27M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BARRIER THERAPEUTICS INC No price found
InvestorPERSEUS SOROS BIOPHARMACEUTICAL FUND LP owns 2,754,738 units of Common Stock, $.0001 par value and 2,324,734 units of Common Stock, par value $.0001 per share ("Common Stock").acquired a total of 2,754,738 shares in BARRIER THERAPEUTICS INC, PERSEUS also disposed a total of 430,004 shares of BARRIER THERAPEUTICS INC equalling to $8,385,078.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -15.61% | -430.00K |
$19.50 | -$8,385,078.00 | 2.32M |
Feb 15
| |||
Form 4
|
∞
| 2.75M |
—
|
—
| 2.75M |
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adams Respiratory Therapeutics, Inc. No price found
InvestorPERSEUS SOROS BIOPHARMACEUTICAL FUND LP owns 3,372,918 units of Common Stock, par value $0.01 per share and 5,088,376 units of Common Stock. In the year 2005 PERSEUS SOROS BIOPHARMACEUTICAL FUND LP filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.71% | -1.72M |
$43.75 | -$75,051,287.50 | 3.37M |
Dec 14
| |||
Form 4
| +52.42% | 3.53M |
$15.81 | -$25,438,290.00 | 10.27M |
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||